Zobrazeno 1 - 10
of 39
pro vyhledávání: '"D M Mkheidze"'
Autor:
V V Ptushkin, K L Chimishkyan, N V Zhukov, D Sh Osmanov, L Yu Andreeva, N N Tupitsyn, V В Larionova, D M Mkheidze, I V Poddubnaya
Publikováno v:
Терапевтический архив, Vol 78, Iss 1, Pp 65-68 (2003)
Aim. To study efficacy of htuximab in patients with resistant B-cell lymphoma on high-dose chemotherapy. Material and methods. From September 2000 to April 2002 we studied efficacy and tolerance of rituximab at different stages of high-dose chemother
Externí odkaz:
https://doaj.org/article/b52d189914304434bab85b3da9b4bdab
Autor:
V V Ptushkin, N V Zhukov, S V Minenko, D M Mkheidze, L Yu Grivtsova, A Yu Popov, E P Grishunenkova, K L Chimishkyan
Publikováno v:
Современная онкология, Vol 8, Iss 1, Pp 49-51 (2006)
Высокодозная химиотерапия с трансплантацией аутологичных клеток-предшественников гемопоэза является стандартным методом лечения бол
Externí odkaz:
https://doaj.org/article/ce668871653a441ba6a4705118cc1d6c
Autor:
Garanin Dv, Yu. N. Solov'ev, N. A. Pirogova, S. A. Yagnikov, N. G. Kozlovskaya, D. M. Mkheidze, Mitin Vn
Publikováno v:
Bulletin of Experimental Biology and Medicine. 126:1042-1045
Transfusion of allogenic bone marrow to prevent metastasizing of osteogenic sarcoma was studied as an alternative to aggressive chemotherapy in cases when it is impossible to preserve the limb. The study was carried out on 62 dogs with spontaneous os
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26865a44bef80a29f1932afd0602620a
https://doi.org/10.1007/bf02447316
https://doi.org/10.1007/bf02447316
Autor:
M I, Davydov, A Iu, Baryshnikov, N V, Zhukov, G L, Mentkevich, I S, Dolgopolov, D M, Mkheidze, V V, Ptushkin, K L, Chimishkian
Publikováno v:
Vestnik Rossiiskoi akademii meditsinskikh nauk. (9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::51c336d7a798e6db3ad4e87cb55f81fc
https://pubmed.ncbi.nlm.nih.gov/15526688
https://pubmed.ncbi.nlm.nih.gov/15526688
Autor:
V V, Ptushkin, K L, Chimishkian, N V, Zhukov, D Sh, Osmanov, L Iu, Andreeva, N N, Tupitsyn, V B, Larionova, D M, Mkheidze, N V, Poddubnaia
Publikováno v:
Terapevticheskii arkhiv. 75(1)
To study efficacy of rituximab in patients with resistant B-cell lymphoma on high-dose chemotherapy.From September 2000 to April 2002 we studied efficacy and tolerance of rituximab at different stages of high-dose chemotherapy. The treatment was give
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b33465681f190bba922e33c46b98db07
https://pubmed.ncbi.nlm.nih.gov/12652962
https://pubmed.ncbi.nlm.nih.gov/12652962
Autor:
M Ia, Iankelevich, I S, Dolgopolov, L Iu, Andreeva, R S, Ravshanova, D G, Izhogin, D M, Mkheidze, E V, Ogorodnikova, G L, Mentkevich
Publikováno v:
Vestnik Rossiiskoi akademii meditsinskikh nauk. (6)
The authors examined 8 patients with pretreated relapsing or resistant solid tumors (Wilms'--4, rhabdomyosarcoma--3, synovial sarcoma--1) who received 16 courses of chemotherapy: iphosphamide, 1800 mg/m2/day (days 1-5), vepeside, 100 mg/m2/day (days
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a8e94a533c593e03fc9709d94e912ccf
https://pubmed.ncbi.nlm.nih.gov/10943156
https://pubmed.ncbi.nlm.nih.gov/10943156
Autor:
V N, Mitin, D M, Mkheidze, Iu N, Solov'ev, S A, Iagnikov, N G, Kozlovskaia, D V, Garanin, N A, Pirogova
Publikováno v:
Biulleten' eksperimental'noi biologii i meditsiny. 126(10)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9b65a8f4017492d20ee9dd7921562755
https://pubmed.ncbi.nlm.nih.gov/9825148
https://pubmed.ncbi.nlm.nih.gov/9825148
Autor:
V V, Ptushkin, K P, Laktionov, S M, Portnoĭ, V B, Larionova, N V, Zhukov, D M, Mkheidze, K L, Chimishkian
Publikováno v:
Voprosy onkologii. 44(4)
High-dose chemotherapy using transplantation of hemopoietic precursor cells offers much advantage for treatment of prognostically unfavorable cancers of the breast. Both experimental and clinical evidence points to a potential of raising antitumor ef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ef316ca722031efff1a1c822a6a9f705
https://pubmed.ncbi.nlm.nih.gov/9807205
https://pubmed.ncbi.nlm.nih.gov/9807205
Autor:
V V, Ptuskin, A L, Uss, E A, Demina, Iu V, Chervonobab, N F, Milanovich, N N, Tupitsyn, V B, Larionova, Z E, Batan, N E, Kondrat'eva, V A, Zmachinskiĭ, L A, Andreeva, V M, Snegir', D M, Mkheidze, K L, Chimishkian
Publikováno v:
Terapevticheskii arkhiv. 69(10)
Eighteen patients with relapsed or refractory Hodgkin's disease (HD) have been treated with high-dose chemotherapy (BEAM regimen) followed by autologous peripheral stem cells and/or bone marrow rescue. There were no treatment-related deaths. Overall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ee3f2b7de99601c1cee4b5bdb1715f78
https://pubmed.ncbi.nlm.nih.gov/9471790
https://pubmed.ncbi.nlm.nih.gov/9471790